We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The House Rules committee on Tuesday held the first hearing on a proposal to create a national health program that would allow HHS to negotiate drug prices. Read More
The FDA expects companies to build up “robust IT systems and internal processes” to make sure they are tracking and reporting adverse events. Read More
The EMA’s Committee for Medicinal Products for Human Use (CHMP) flagged 13 medicines for approval at its April meeting, including two orphan medications and a biosimilar. Read More
Washington state regulators have awarded AbbVie an exclusive contract to help the state rid itself of Hepatitis C within the next decade—the nation’s second state to adopt a subscription payment model. Read More
Drugmakers and regulators urgently need to create a pipeline of drugs to treat the growing threat of antibiotic-resistant diseases, the World Health Organization says in a new report issued Monday. Read More